HSD17B13 and metabolic dysfunction-associated steatotic liver disease: To validate this assumption, we detected HSD17B13 expression in liver tissues from murine models of NAFLD induced by methionine-choline-deficient diet (MCD), choline-deficient and high-fat diet (CDHFD), high-fat diet (HFD), diethylnitrosamine (DEN), bile-duct ligation (BDL), and carbon tetrachloride (CCl4).